Research Article - Current Pediatric Research (2022) Volume 26, Issue 5
A study of clinical profile of Multi Inflammatory Syndrome Child (MIS-C) patients from 1 month to 12 years admitted to paediatric ward in a tertiary care centre in Western Maharashtra.
Background: Multisystem Inflammatory Syndrome-Child (MIS-C) is a rare but life-threatening complication of COVID-19 in children. Objective: To study clinical profile of patients with MIS-C in pediatric ward in a tertiary care centre in Western Maharashtra Study design: Observational study Participants: Patients satisfying MIS-C criteria by WHO during the study period Results: 3.1 % (23 cases) of the total admissions during the study period in the pediatric ward were cases of MIS-C. The median age of MIS-C cases was 5 years (1.5 months to 12 years). Out of 23 cases, 10 cases were with shock, 7 cases without shock and 6 cases were of Kawasaki phenotype. They were treated with steroids alone, steroids plus IVIG or only symptomatic treatment. There was mortality in 1 patient (4.3%). Conclusion: Steroids and IVIG can be lifesaving in MIS-C cases if diagnosed early and given prompt treatment.Author(s): Shraddha Laxman Khalate*, Sudhir Sarawade, Vijaylaxmi Sharma, Pallavi Kharade